In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure

High dose bee venom exposure in beekeepers by natural bee stings represents a model to understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished T cell–related cutaneous late-phase swelling to bee stings in parallel with suppressed allergen-specific T cell proliferation and T helper type 1 (Th1) and Th2 cytokine secretion. After multiple bee stings, venom antigen–specific Th1 and Th2 cells show a switch toward interleukin (IL) 10–secreting type 1 T regulatory (Tr1) cells. T cell regulation continues as long as antigen exposure persists and returns to initial levels within 2 to 3 mo after bee stings. Histamine receptor 2 up-regulated on specific Th2 cells displays a dual effect by directly suppressing allergen-stimulated T cells and increasing IL-10 production. In addition, cytotoxic T lymphocyte–associated antigen 4 and programmed death 1 play roles in allergen-specific T cell suppression. In contrast to its role in mucosal allergen tolerance, transforming growth factor β does not seem to be an essential player in skin-related allergen tolerance. Thus, rapid switch and expansion of IL-10–producing Tr1 cells and the use of multiple suppressive factors represent essential mechanisms in immune tolerance to a high dose of allergens in nonallergic individuals.

• Publication year

  2008

• Venue

  Journal of Experimental Medicine

• Publication date

  2008-11-24

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1084/jem.20080193PMID 19001136PMCID 2585856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines

  2008cited by this paper
• Treg cells: guardians for life

  2007cited by this paper
• Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

  2007cited by this paper
• Emerging Challenges in Regulatory T Cell Function and Biology

  2007cited by this paper
• Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo

  2006cited by this paper
• Healthy immune response to allergens: T regulatory cells and more.

  2006cited by this paper
• Allergy and hypersensitivity: mechanisms of allergic disease.

  2006cited by this paper
• Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy

  2006cited by this paper
• The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells

  2006cited by this paper
• Immunological mechanisms of allergen-specific immunotherapy

  2006cited by this paper
• Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.

  2006cited by this paper
• Fel d 1‐derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+ interferon‐γ+ T helper type 1 cells to sites of allergen‐induced late‐phase skin reactions in cat‐allergic subjects

  2005cited by this paper
• Peptide-based therapeutic vaccines for allergic and autoimmune diseases

  2005cited by this paper
• Diagnosis of Hymenoptera venom allergy

  2005cited by this paper
• Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists.

  2005cited by this paper
• Oral tolerance

  2005cited by this paper
• Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

  2004cited by this paper
• Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

  2004cited by this paper
• SARA and Hgs attenuate susceptibility to TGF‐β 1‐mediated T cell suppression

  2003cited by this paper
• Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes

  2003cited by this paper
• Histamine enhances TGF‐β1‐mediated suppression of Th2 responses

  2003cited by this paper
• Critical role of IL-10 in the induction of low zone tolerance to contact allergens.

  2003cited by this paper
• Histamine enhances TGF-beta1-mediated suppression of Th2 responses.

  2003cited by this paper
• IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

  2003cited by this paper
• Genetic Reprogramming of Primary Human T Cells Reveals Functional Plasticity in Th Cell Differentiation

  2003cited by this paper
• Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

  2003cited by this paper
• Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines

  2002cited by this paper
• PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2

  2002cited by this paper
• In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines

  2002cited by this paper
• Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora1

  2002cited by this paper
• Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization.

  2001cited by this paper
• Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors

  2001cited by this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation

  2000cited by this paper
• Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

  2000cited by this paper
• Oral tolerance.

  2000cited by this paper
• A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding

  2000cited by this paper
• HLA-DR Restricted Peptide Candidates for Bee Venom Immunotherapy

  2000cited by this paper
• Enrichment and detection of live antigen‐specific CD4+ and CD8+ T cells based on cytokine secretion

  1999cited by this paper
• Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

  1999cited by this paper
• Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

  1998cited by this paper
• Role of interleukin 10 in specific immunotherapy.

  1998cited by this paper
• Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

  1998cited by this paper
• IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects.

  1998cited by this paper
• Histamine inhibits the production of interleukin-12 through interaction with H2 receptors.

  1998cited by this paper
• Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants

  1998cited by this paper
• Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects.

  1997cited by this paper
• Natural history of Hymenoptera venom sensitivity in adults.

  1997cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• Oral tolerance.

  1994cited by this paper
• Expression cloning and characterization of a human IL-10 receptor.

  1994cited by this paper
• Allergenic exposure, IgE-mediated sensitization, and related symptoms in lawn cutters.

  1994cited by this paper
• T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2.

  1993cited by this paper
• "Infectious" transplantation tolerance

  1993cited by this paper
• Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

  1986cited by this paper

• Pattern of sensitization to yellow jacket venom and expression of recombinant antigen 5 (Ves v 5) from yellow jacket venom

  2025cites this paper
• Trichinella spiralis extracellular vesicles induce anti-inflammatory and regulatory immune responses in vitro.

  2025cites this paper
• Type 2 immunity in allergic diseases

  2025cites this paper
• Role of IgG4 Antibodies in Human Health and Disease

  2025cites this paper
• Are There General Features of How Immune Responses Are Regulated That Can Provide Clues to How Remitting/Relapsing Multiple Sclerosis May Be Treated?

  2024cites this paper
• Disturbances of Ruminal Microbiota and Liver Inflammation, Mediated by LPS and Histamine, in Dairy Cows Fed a High-Concentrate Diet

  2024cites this paper
• A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases

  2024cites this paper
• Point‐of‐Care Health Diagnostics and Food Quality Monitoring by Molecularly Imprinted Polymers‐Based Histamine Sensors

  2024cites this paper
• IgG4 Subclass of Immunoglobulins; Immunobiology and Roles in Relation to Human Diseases.

  2024influential citation
• Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases

  2024cites this paper
• H2 antihistamines: May be useful for combination therapies in cancer?

  2024cites this paper
• Majie Cataplasm Alleviates Asthma by Regulating Th1/Th2/Treg/Th17 Balance

  2024cites this paper
• Hot topics in allergen immunotherapy, 2023: Current status and future perspective

  2023cites this paper
• Determination of Tr1 cell populations correlating with distinct activation states in acute IAV infection.

  2023cites this paper
• Der p 1-specific Treg and Breg cells in allergen immunotherapy and mechanism of immune tolerance

  2023cites this paper
• Relapsing/remitting multiple sclerosis: A speculative model and its implications for a novel treatment

  2023cites this paper
• Phytoestrogen-Based Hormonal Replacement Therapy Could Benefit Women Suffering Late-Onset Asthma

  2023cites this paper
• Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway.

  2023cites this paper
• Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease

  2023cites this paper
• The unique properties of IgG4 and its roles in health and disease

  2023cites this paper
• Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease

  2023cites this paper
• Effects of subcutaneous immunotherapy in allergic rhinitis children sensitive to dust mites.

  2023cites this paper
• Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets

  2023cites this paper
• B cells: The many facets of B cells in allergic diseases.

  2023cites this paper
• Extract-Shaped Immune Repertoires as Source for Nanobody-Based Human IgE in Grass Pollen Allergy

  2023cites this paper
• Mechanistic insights into silica nanoparticle–allergen interactions on antigen presenting cell function in the context of allergic reactions

  2023cites this paper
• Type I regulatory T cells in malaria: of mice and men

  2023cites this paper
• Treg-specific deletion of the phosphatase SHP-1 impairs control of inflammation in vivo

  2023cites this paper
• The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions.

  2023cites this paper
• Adaptive T cell tuning in immune regulation and immunotherapy of autoimmune diseases.

  2022cites this paper
• Regulatory T cells in inflammation and resolution of acute lung injury

  2022cites this paper
• IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies

  2022cites this paper
• High prevalence of IgE sensitization to inactivated influenza vaccines, yet robust IgG4 responses, in a healthy pediatric population

  2022cites this paper
• Immunomodulation by foods and microbes: Unravelling the molecular tango

  2022cites this paper
• Tonsillar transcriptional profiles in atopic and non‐atopic subjects

  2022cites this paper
• Mechanisms of allergen immunotherapy supporting its disease-modifying effect.

  2022cites this paper
• New approaches to immunotherapy in house dust mite allergy

  2022cites this paper
• Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy

  2022cites this paper
• Reported Cases and Diagnostics of Occupational Insect Allergy: A Systematic Review

  2022cites this paper
• Novel populations of Tr1 cells contribute to the resolution of acute influenza A virus infection

  2022cites this paper
• Biological Effects of Animal Venoms on the Human Immune System

  2022cites this paper
• A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity

  2022cites this paper
• Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma

  2022cites this paper
• Malaria drives unique regulatory responses across multiple immune cell subsets

  2022cites this paper
• Plasma Metabolites and Gut Microbiota Are Associated With T cell Imbalance in BALB/c Model of Eosinophilic Asthma

  2022cites this paper
• Type 1 regulatory T cell-mediated tolerance in health and disease

  2022cites this paper
• Mechanisms and biomarkers of successful allergen-specific immunotherapy

  2022cites this paper
• Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

  2021cites this paper
• New Insights Into Potential Benefits of Bioactive Compounds of Bee Products on COVID-19: A Review and Assessment of Recent Research

  2021cites this paper
• Effects of nasopharyngeal microbiota in respiratory infections and allergies

  2021cites this paper
• Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e‐diary AllergyMonitor®

  2021cites this paper
• Abundance and Stability as Common Properties of Allergens

  2021influential citation
• Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy

  2021cites this paper
• Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity

  2021cites this paper
• The role of cytokines in determining the Th1/Th2 phenotype of an immune response: Coherence of the T cell response and the Cytokine Implementation Hypothesis

  2021cites this paper
• Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study

  2021cites this paper
• Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART)

  2021cites this paper
• Helios negative Regulatory T-cells as a key factor of immune tolerance in non-allergic beekeepers.

  2021cites this paper
• New Biomarkers of Hymenoptera Venom Allergy in a Group of Inflammation Factors

  2021cites this paper
• Modern ideas about mechanisms of allergen-specific immunotherapy

  2021cites this paper
• The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases

  2021cites this paper
• Conversion of Anergic T Cells Into Foxp3- IL-10+ Regulatory T Cells by a Second Antigen Stimulus In Vivo

  2021cites this paper
• Histamine in cancer immunology and immunotherapy. Current status and new perspectives

  2021cites this paper
• Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review

  2021cites this paper
• B regulatory cells in allergy

  2020cites this paper
• Histamine receptors and COVID-19

  2020cites this paper
• A T cell–myeloid IL-10 axis regulates pathogenic IFN-γ–dependent immunity in a mouse model of type 2–low asthma

  2020cites this paper
• Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species

  2020cites this paper
• High Risk COVID-19: Potential Intervention at Multiple Points in the COVID-19 Disease Process Via Prophylactic Treatment with Azithromycin or Bee Derived Products

  2020cites this paper
• Systems and Synthetic Immunology

  2020cites this paper
• Tolerance mechanisms in allergen immunotherapy

  2020cites this paper
• Bisphenol A Exacerbates Allergic Inflammation in an Ovalbumin-Induced Mouse Model of Allergic Rhinitis

  2020cites this paper
• EAACI Allergen Immunotherapy User's Guide

  2020influential citation
• Role of Regulatory T Lymphocytes in Health and Disease

  2020cites this paper
• The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer

  2020cites this paper
• Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses.

  2020cites this paper
• Venom immunotherapy in Europe and the United States

  2020cites this paper
• Venom immunotherapy in Europe and the United States

  2020influential citation
• Thoracic Involvement in IgG4-Related Disease

  2020cites this paper
• Allergen immunotherapy in children with respiratory allergic diseases.

  2020cites this paper
• Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New?

  2020cites this paper
• The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid

  2020cites this paper
• Clinical Utility of Rush Venom Immunotherapy: Current Status

  2020cites this paper
• Allergen Immunotherapy in Children User’s Guide

  2020influential citation
• [Allergic rhinitis' treatment in children in Argentina. Update].

  2020cites this paper
• Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy*

  2020cites this paper
• Role of Der p 1–specific B cells in immune tolerance during 2 years of house dust mite–specific immunotherapy

  2019cites this paper
• Rush desensitization with a single antigen induces subclinical activation of mast cells and protects against bystander challenge in dually sensitized mice

  2019cites this paper
• Circulating Serum Levels of Fox P3, GATA-3 and IL-17 A as Potential Biomarkers in Patients with Symptomatic Asthma

  2019cites this paper
• [Analyses of Foxp3+ Treg cells and Tr1 cells in subcutaneous immunotherapy-treated allergic individuals in humans and mice].

  2019cites this paper
• B-cell responses in allergen immunotherapy.

  2019cites this paper
• Sulfatide-activated type II NKT cells suppress immunogenic maturation of lung dendritic cells in murine models of asthma.

  2019cites this paper
• Natural Tr1-like cells do not confer long-term tolerogenic memory

  2019cites this paper
• The influence of Toll-like receptor 4 activation in human CD4 T cell function

  2019cites this paper
• Bee Venom Immunotherapy: Current Status and Future Directions

  2019cites this paper
• Allergy in an Evolutionary Framework

  2019cites this paper
• Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?

  2019cites this paper
• The use of biologics for immune modulation in allergic disease

  2019cites this paper
• T-reg Homeostasis and Functions in Aging

  2019cites this paper
• The build-up phase outcome of subcutaneous immunotherapy for pediatric allergic asthma: A retrospective cohort study from Surabaya, Indonesia

  2019cites this paper